Fashionable, but what is their real clinical usefulness? NLR, LMR, and PLR as a promising indicator in colorectal cancer prognosis: A systematic review

A Misiewicz, V Dymicka-Piekarska - Journal of inflammation …, 2023 - Taylor & Francis
The link between inflammation and cancer is still an attractive subject of many studies
because systemic inflammatory response has been proven to play a pivotal role in cancer …

Prognostic and predictive biomarkers in patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy

A Martín-Carnicero, E Ramalle-Gomara… - Journal of Clinical …, 2022 - mdpi.com
Neoadjuvant chemoradiotherapy (CRT) is one of the standards of care in locally advanced
rectal cancer (LARC). This retrospective study examines clinical, analytical, and pathological …

The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and …

E Smorodin, V Chuzmarov, T Veidebaum - Current Oncology, 2024 - mdpi.com
Melatonin is a multifunctional hormone regulator that maintains homeostasis through
circadian rhythms, and desynchronization of these rhythms can lead to gastrointestinal …

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients

R Kleef, M Dank, M Herold, EI Agoston, J Lohinszky… - Scientific Reports, 2023 - nature.com
In the last decade, the use of immunomodulating treatments (IMT) at integrative oncology
providers (IOP) increased. IMTs are used to modulate the tumor microenvironment, which …

[HTML][HTML] The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis

P Özcan, Ö Düzgün - Journal of Personalized Medicine, 2024 - mdpi.com
Background: Colorectal cancer peritoneal carcinomatosis (CRC PC) necessitates
preoperative assessment of inflammatory markers to predict postoperative outcomes and …

Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study

Z Wang, S Zhao, X Zhang, X Mao, G Yang, M Yuan… - PeerJ, 2024 - peerj.com
Objective Fruquintinib, a novel anti-angiogenic targeted drug, has gained widespread
application in the treatment of metastatic colorectal cancer. This study aims to investigate the …

[引用][C] Ralf Kleef, Magdolna Dank 2, Magdolna Herold 2, 3, Emese Irma Agoston 4, Julia Lohinszky 3

E Martinek - Scientific Reports, 2023